Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial
Article in The Lancet (October 2023)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Article in The Lancet (October 2023)
Article in Trials (July 2022)
Article in Arquivos de Gastroenterologia (March 2022)